Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aave (AAVE) vs Bio Protocol (BIO) Price & Performance

Aave
Bio Protocol

Price performance

Price movement over the last 24 hours

Key statistics

Aave vs Bio Protocol — how do they compare? Aave trades at Rp1,589,866 (market cap Rp24,63T, Rp4,12T 24h volume), while Bio Protocol trades at Rp502.9 (market cap Rp1,13T, Rp314,5M 24h volume). The key difference: Aave is far larger — about 21.8× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Aave's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Aave for 102 Days and Bio Protocol for 16 Days on average.

AAVEBIO
Market Cap
Rp24,63TRp1,13T
Volume (24h)
Rp4,12TRp314,5M
Circulating Supply
15,4M AAVE2,2B / 3,3B BIO (68%)
Typical Hold Time
102 Days16 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aave

Aave (AAVE) is trading at Rp1,572,179 with a market cap of Rp24.14T, showing a bullish technical signal driven by moving averages. The current price sits above key support levels, with RSI in neutral territory. Recent protocol upgrades and ecosystem growth, such as the deployment on new chains, support fundamental strength.

Overall outlook is cautiously optimistic, with opportunities in DeFi adoption and protocol innovation. Major risks include high volatility, regulatory uncertainty in crypto, and liquidity fluctuations. Investors should monitor on-chain activity and broader market trends.

Bio Protocol

Bio Protocol (BIO) trades at Rp503.72 with a market cap of Rp1.12T, showing a bearish technical outlook as indicated by moving averages. The token's circulating supply is 2.2M out of a max 3.3M, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though specific protocol updates are limited. Key support lies at Rp430, with resistance at Rp522.

Overall outlook is cautious due to bearish signals and neutral oscillators. Opportunities include potential rebounds from oversold RSI levels, but risks involve low liquidity and regulatory uncertainties in the crypto space. Investors should monitor network activity and exchange developments closely.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

AAVE
55% Buy45% Sell
Avg holding period · 102 Days
BIO
67% Buy33% Sell
Avg holding period · 16 Days

Top news

Latest headlines on both assets

About Aave

AAVE is one of the biggest and earliest decentralized finance protocols. It enables users to lend and borrow a wide range of cryptocurrencies using both fixed and variable interest rates.

Read more on AAVE

About Bio Protocol

BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.

Read more on BIO